Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine

Schizophr Res. 2023 May:255:14-16. doi: 10.1016/j.schres.2023.03.011. Epub 2023 Mar 9.

Authors

Wen-Huei Siao¹, Fang-Yu Chang¹, Yi-Chyan Chen²

Affiliations

¹ Department of Psychiatry, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
² Department of Psychiatry, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; Department of Psychiatry, School of Medicine, Tzu Chi University, Hualien, Taiwan. Electronic address: yichyanc@tzuchi.com.tw.

No abstract available

Keywords: Acute psychosis; COVID-19; Memantine; Neuroinflammation; mRNA vaccine.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

2019-nCoV Vaccine mRNA-1273
Anxiety
COVID-19* / prevention & control
Humans
Memantine / therapeutic use
Psychotic Disorders* / complications
Psychotic Disorders* / drug therapy

Substances

2019-nCoV Vaccine mRNA-1273
Memantine